Triamcinolone Acetonide
Brands: Triderm · Triamcinolone Acetonide
22 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 50 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Triderm · Triamcinolone Acetonide
Average across 50 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 26 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 14 | SUPPLYING |
| Proficient Rx LP | repackager | 13 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 11 | SUPPLYING |
| A-S Medication Solutions | repackager | 10 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 8 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 8 | SUPPLYING |
| Direct_Rx | repackager | 8 | SUPPLYING |
| Crown Laboratories | unknown | 8 | SUPPLYING |
| Padagis Israel Pharmaceuticals Ltd | generic | 7 | SUPPLYING |
| NorthStar RxLLC | relabeler | 7 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 7 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 7 | SUPPLYING |
| E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | unknown | 6 | SUPPLYING |
| Cosette Pharmaceuticals, Inc. | unknown | 5 | SUPPLYING |
+ 7 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness. — Recalling firm: Padagis US LLC — Nationwide in the USA
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%. — Recalling firm: Fougera Pharmaceuticals Inc. — Nationwide.